Thoracic oncology

Gefitinib versus erlotinib as first-line treatment in EGFR mutant advanced lung adenocarcinoma
Chai Chee Shee, Liam Chong Kin, Pang Yong Kek, Kow Keng Siong, Poh Mau Ern, Wong Chee Kuan, Tan Jiunn Liang

European Respiratory Journal Sep 2016, 48 (suppl 60) OA3341; DOI: 10.1183/13993003.congress-2016.OA3341
LATE-BREAKING ABSTRACT: Long-term consequences of central airways stenosis after lung transplantation
Michele Porzio, Andrea Mazzetta, Romain Kessler, Anne Olland

European Respiratory Journal Sep 2016, 48 (suppl 60) OA3331; DOI: 10.1183/13993003.congress-2016.OA3331
Ribcage kinematics during exercise justifies thoracoscopic over thoracotomy lobectomy prompt recovery
Antonella Lo Mauro, Alessandro Palleschi, Emilia Privitera, Melania Chiesa, Margherita Cattaneo, Martina Santambrogio, Mario Nosotti, Andrea Aliverti

European Respiratory Journal Sep 2016, 48 (suppl 60) OA1988; DOI: 10.1183/13993003.congress-2016.OA1988
Revision of descriptors in forthcoming VIII edition of TNM classification of lung cancer: A single center validation study
Luca Bertolaccini, Andrea Viti, Carlo Pomari, Luca Rosario Assante, Simona Paiano, Alberto Terzi

European Respiratory Journal Sep 2016, 48 (suppl 60) OA1991; DOI: 10.1183/13993003.congress-2016.OA1991
Eligibility for lung cancer screening in Australia and the effect on screening eligibility of using spirometry to identify COPD
David Manners, Jennie Hui, Michael Hunter, Alan James, Matthew Knuiman, Annette McWilliams, Siobhain Mulrennan, Bill Musk, Fraser Brims

European Respiratory Journal Sep 2016, 48 (suppl 60) OA1503; DOI: 10.1183/13993003.congress-2016.OA1503
LATE-BREAKING ABSTRACT: Do mesenchymal stromal cells provide an organ-specific tissue niche? – A proteomic matrisome characterization
Sara Rolandsson Enes, Emma Åhrman, Anitha Palani, Oskar Hallgren, Leif Bjermer, Stefan Scheding, Anders Malmström, Johan Malmström, Gunilla Westergren-Thorsson

European Respiratory Journal Sep 2016, 48 (suppl 60) OA503; DOI: 10.1183/13993003.congress-2016.OA503
Role of tumor derived versican in experimental malignant pleural mesothelioma
Apostolos Pappas, Sofia Magkouta, Maria Vazakidou, Ioannis Kalomenidis

European Respiratory Journal Sep 2016, 48 (suppl 60) OA496; DOI: 10.1183/13993003.congress-2016.OA496
Microscopic vessel invasion and visceral pleural invasion are correlated with EMT, cancer stemness and resistance to therapy in lung adenocarcinoma
Shinya Neri, Toshi Menju, Akihiko Yoshizawa, Terumasa Sowa, Hideki Motoyama, Kyoko Hijiya, Toyofumi Chen-Yoshikawa, Akihiro Aoyama, Toshihiko Sato, Makoto Sonobe, Hiroshi Date

European Respiratory Journal Sep 2016, 48 (suppl 60) OA1773; DOI: 10.1183/13993003.congress-2016.OA1773
Folic acid phenotype (FAP) as superior marker to predict pemetrexed response in pleural mesothelioma
Robert Fred Henry Walter, Claudia Vollbrecht, Daniel Christian Christoph, Kurt Werner Schmid, Jens Kollmeier, Helmut Hans Popper, Thomas Mairinger, Fabian Mairinger

European Respiratory Journal Sep 2016, 48 (suppl 60) OA498; DOI: 10.1183/13993003.congress-2016.OA498
Tracheal and bronchial granular cell tumours: A French retrospective study on 30 patients
Maxime Roger, Samy Lachkar, Mathieu Salaun, Michel Febvre, Jean Michel Vergnon, Luc Thiberville

European Respiratory Journal Sep 2015, 46 (suppl 59) PA4865; DOI: 10.1183/13993003.congress-2015.PA4865

Main menu

User menu

Search

Thoracic oncology

Pages

Contact us